Fundraising Fox

LipimetiX Development

Natick, US · Founded 2012 · Delaware corporation

Biotech

Founders & leadership

LipimetiX Development was founded in 2012 by DENNIS I GOLDBERG, PH.D..

DI
DENNIS I GOLDBERG, PH.D.PRESIDENT
PF
PHILLIP FRIDEN, PH.D.VICE PRESIDENT
EM
ERIC M MORREL, PH.D.VICE PRESIDENT
RC
RANDOLPH C STEER, M.D., PH.D.VICE PRESIDENT

Board

JH
JOHN HOLLIMAN, IIISECRETARY AND TREASURER

Reported raises · per SEC filings

Form D private placements

$1M disclosed across 1 round · 2016

▶$1MraisedSep 2016 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • PHILLIP FRIDEN, PH.D.Executive Officer, Director
  • ERIC M MORREL, PH.D.Executive Officer, Director
  • JOHN HOLLIMAN, IIIExecutive Officer, Director
  • DENNIS I GOLDBERG, PH.D.Executive Officer, Director
  • RANDOLPH C STEER, M.D., PH.D.Executive Officer, Director
Amount sold
$1M
First sale
Aug 2016
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Capstone Therapeutics Announces That Its Joint Venture, LipimetiX Development, Inc., Has Closed a Series B-1 Preferred Stock Offeringglobenewswire.com · Aug 2016

Frequently asked questions

Who founded LipimetiX Development?
LipimetiX Development was founded by DENNIS I GOLDBERG, PH.D. in 2012.
How much funding has LipimetiX Development raised?
LipimetiX Development has disclosed $1M raised across 1 round.
Where is LipimetiX Development headquartered?
LipimetiX Development is headquartered in Natick, US.